Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

tersera therapeutics, llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t) - ergomar® is indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called "histaminic cephalalgia". coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine was coadministered, at least one resulting in death. because of the increased risk for ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). ergomar® sublingual tablets may cause fetal harm when administered to pregnant women. ergomar® subli

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

impel pharmaceuticals inc. - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - trudhesa is indicated for the acute treatment of migraine with or without aura in adults. limitations of use trudhesa is not indicated for the preventive treatment of migraine. trudhesa is not indicated for the management of hemiplegic or basilar migraine. trudhesa is contraindicated in patients: - with concomitant use of strong cyp3a4 inhibitors, such as protease inhibitors (e.g., ritonavir, nelfinavir, or indinavir), macrolide antibiotics (e.g., erythromycin or clarithromycin), and antifungals (ketoconazole or itraconazole) [see warnings and precautions (5.1) and drug interactions (7.1)] - with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or patients who have clinical symptoms or findings consistent with coronary artery vasospasm, including prinzmetal's variant angina [see warnings and precautions (5.4)] - with uncontrolled hypertension [see warnings and precautions (5.5)] - with peripheral arterial disease - with sepsis - following vascular surge

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - ergotamine tartrate caffeine - tablets - 1 milligram

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - ergotamine tartrate caffeine - suppositories - 2 milligram

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - atropa belladonna 0.25mg; butalbital 100mg; caffeine 100mg; ergotamine tartrate 2mg - suppository - 0.25/100/100/2mg - active: atropa belladonna 0.25mg butalbital 100mg caffeine 100mg ergotamine tartrate 2mg

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - atropa belladonna 0.25mg; butalbital 100mg; caffeine 100mg; ergotamine tartrate 2mg - suppository - 0.25/100/2/100mg - active: atropa belladonna 0.25mg butalbital 100mg caffeine 100mg ergotamine tartrate 2mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - ergotamine tartrate; cyclizine hydrochloride; caffeine hydrate - oral tablet - 2mg ; 50mg ; 100mg

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amdipharm ltd. - dihydroergotamine mesilate 4 mg/ml - nasal spray, solution - 4 mg/ml - dihydroergotamine mesilate 4 mg/ml - dihydroergotamine

Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - caffeine, ergotamine tartrate - tablet - 1 , 100 mg

Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

amdipharma, ireland - caffeine,ergotamine tartrate,hydrochlorothiazide,eprosartan mesilate - tablet - 100,1,12.5,600 mg,